Author

O. Ferraris

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

E. Simon-Loriere· 2 shared F. Iseni· 2 shared J.-N. Tournier· 2 shared A. Baeri· 1 shared A. Baidaliuk· 1 shared A. Ferrier· 1 shared A. Lamit· 1 shared A.-L. Favier· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

E. Simon-Loriere

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

APOBEC3F is the main source of editing identified during the 2022 outbreak of human monkeypox virus

R. Suspene, K. A. Raymond, L. Boutin, S. Guillier, F. Lemoine, O. Ferraris, J.-N. Tournier, F. Iseni, E. Simon-Loriere, J.-P. Vartanian

The paper identifies APOBEC3F as the main source of hypermutation in MPXV during the 2022 outbreak, showing its role in generating G->A mutations and subsequent viral evolution.

bioRxiv · Jan 6, 2023 · PreprintMicrobiology

Tecovirimat is highly efficient on the Monkeypox virus lineage responsible for the international 2022 outbreak

G. Frenois-Veyrat, F. Gallardo, O. Gorge, E. Marcheteau, O. Ferraris, A. Baidaliuk, A.-L. Favier, C. Enfroy, X. Holy, J. Lourenco, R. Khoury, F. Nolent, D. W. Grosenbach, D. Hruby, A. Ferrier, , J.-N. Tournier

This study tests tecovirimat's efficacy against the 2022 MPXV outbreak strain, showing nanomolar activity compared to cidofovir's micromolar activity.

bioRxiv · Jul 19, 2022 · PreprintMicrobiology

Identification of oncolytic vaccinia restriction factors in canine high-grade mammary tumor cells using single-cell transcriptomics

B. Cambien, K. Lebrigand, A. Baeri, N. Nottet, C. Compin, A. Lamit, O. Ferraris, C. Peyrefitte, V. Magnone, J. Henriques, L.-E. Zaragosi, S. Giorgetti-Peraldi, F. Bost, M. Gautier-Isola, R. Rezzonico, , G. Vassaux

This paper uses single-cell transcriptomics to identify DDIT4 as a resistance factor against oncolytic vaccinia virus in canine TNBC cells.

bioRxiv · May 29, 2020Cancer Biology